Al-Tawil Mohammed, Geragotellis Alexander, Jubouri Matti, Tan Sven Zcp, Mohammed Idhrees, Williams Ian, Bashir Mohamad
Faculty of Medicine, Al-Quds University, Jerusalem, Palestine.
University of Cape Town Medical School, Cape Town, South Africa.
Asian Cardiovasc Thorac Ann. 2023 Sep;31(7):549-556. doi: 10.1177/02184923221099771. Epub 2022 May 9.
Uncomplicated type B aortic dissection (unTBAD) comprises the estimated majority of type B aortic dissection (TBAD), presenting without any of the complications associated with complicated TBAD (coTBAD). Although first-line treatment for coTBAD is thoracic endovascular aortic repair (TEVAR), and despite the fact that TEVAR has proven its safety and effectiveness in the treatment of unTBAD, unTBAD is still being predominantly managed conservatively with medical therapy, with a small proportion of patients being offered TEVAR.
The main scope of this review is to highlight the evidence in the literature of the demographic characteristics and associated co-morbidities of unTBAD patients undergoing TEVAR in order to produce a risk stratification system to achieve favourable outcomes.
A comprehensive literature search was conducted using multiple electronic databases including PubMed, Ovid, Scopus, and EMBASE.
Multiple demographic characteristics and associated co-morbidities of unTBAD patients affecting TEVAR outcomes were identified, assessed, and investigated, including age, gender, race, genetics, medical conditions, such as hypertension and diabetes, and lifestyle factors such as smoking. Most factors were associated with increased risks of mortality and morbidity, while others, such as race, were identified as being protective against those when it comes to TEVAR.
Despite the favourable results yielded by TEVAR in unTBAD, there remains a grey area concerning its management. Thus, it is important to incorporate the demographics and co-morbidities of unTBAD patients' when into clinical judgement when assessing indications for TEVAR intervention to ensure optimum results can be achieved.
单纯性B型主动脉夹层(unTBAD)估计占B型主动脉夹层(TBAD)的大多数,其表现为无复杂TBAD(coTBAD)相关的任何并发症。尽管coTBAD的一线治疗是胸主动脉腔内修复术(TEVAR),并且尽管TEVAR已在unTBAD治疗中证明了其安全性和有效性,但unTBAD仍主要采用药物保守治疗,只有一小部分患者接受TEVAR治疗。
本综述的主要范围是强调文献中关于接受TEVAR治疗的unTBAD患者的人口统计学特征和相关合并症的证据,以便建立一个风险分层系统以实现良好的治疗效果。
使用包括PubMed、Ovid、Scopus和EMBASE在内的多个电子数据库进行了全面的文献检索。
确定、评估和研究了影响TEVAR治疗效果的unTBAD患者的多种人口统计学特征和相关合并症,包括年龄、性别、种族、遗传学、高血压和糖尿病等疾病状况以及吸烟等生活方式因素。大多数因素与死亡率和发病率增加的风险相关,而其他因素,如种族,在TEVAR治疗方面被确定为具有保护作用。
尽管TEVAR在unTBAD治疗中取得了良好的效果,但其管理仍存在灰色地带。因此,在评估TEVAR干预指征时,将unTBAD患者的人口统计学和合并症纳入临床判断非常重要,以确保能够取得最佳效果。